Skip to main content

Share story

AI

Key findings about how Americans view artificial intelligence

Key findings about how Americans view artificial intelligence Image: Primary
Pew Research Center drew on five years of surveys for 13 findings on how Americans use and view artificial intelligence. AI has become part of everyday life for many at work, school, in health care and beyond. The public remains cautious but somewhat open to potential benefits. Half of U.S. adults say increased AI use in daily life makes them more concerned than excited, per a June 2025 survey. Just 10 percent say they are more excited than concerned. Another 38 percent say they are equally concerned and excited. More Americans express concern now than in 2021, when 37 percent said they were more concerned than excited. Concern is lower in many of the 24 other countries polled. Americans are generally concerned about effects on creativity and relationships but more open to AI for data analysis. They are more optimistic about AI in medical care, with 44 percent seeing a positive impact over the next 20 years. Views are more negative for education and jobs, at 24 percent and 23 percent positive respectively. A majority of teens use AI chatbots, with 64 percent of those ages 13 to 17 reporting use in a fall 2025 survey. Teens most commonly use them for searching information and schoolwork. A growing share of workers, now 21 percent, say at least some of their work involves AI.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from Pew Research Center and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.